Heritable human genome editing: the National Academies/Royal Society report
By Peter Mills,
Nuffield Council on Bioethics
| 09. 08. 2020
The Consensus Study Report of the International Commission on the Clinical Use of Human Germline Genome Editing convened by the US National Academies of Medicine and Sciences and the UK’s Royal Society was published on 3 September.
Heritable human genome editing is a substantial report and stands as a worthy contribution to discussion of heritable human genome editing (HHGE) in the English-speaking world alongside the National Academies’ earlier (and broader) report, Human Genome Editing, science, ethics, and governance (2017) and our own Nuffield Council report, Genome editing and human reproduction: social and ethical issues (2018).
There are many good things about this report. It is clear, thoughtful and detailed. The Commission has bent itself earnestly to fulfilling the task given to it by the commissioning academies. The coverage of the current state of the science, the prospects for the use of HHGE in the clinic, and the presentation of its potential applications manages to be both thorough and readable. It strives constantly to keep its feet on the ground, both through repeated reference to the technical uncertainties that should still...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...